Hirschsprung's disease (HSCR) is characterized by a non-propulsive dis
tal intestinal segment (usually colon) leading to a functional obstruc
tion. An absence of ganglia in the affected segment explains the synon
ymous term <<aganglionosis coli>>. The lack of peristalsis is partly d
ue to a deficient intestinal smooth muscle relaxation based on an abse
nce of non-adrenergic, non-cholinergic (NANC) inhibitory innervation.
Morphological studies using conventional microscopy, immunohistochemis
try and immunochemistry against general neuronal markers and neuropept
ides have been used to characterize the disturbed NANC innervation in
HSCR. An increased cholinergic and adrenergic innervation is registere
d in the aganglionic segment in spite of the lack of neuronal cell bod
ies: Neuropeptides like vasoactive intestinal peptide (VIP), pituitary
adenylate cyclase-activating polypeptide (PACAP), gastrin-releasing p
eptide (GRP), calcitonin gene-related peptide (CGRP), substance P (SP)
, enkephalins and galanin immunoreactive nerve fibres are all reduced
in number in the aganglionic segment. In contrast, neuropeptide Y (NPY
)-containing nerve fibres are increased in number in the diseased segm
ent, probably reflecting the adrenergic hyper-innervation. General neu
ronal markers including chromogranins have been used to map the neuron
al network in the HSCR intestine and also to investigate the endocrine
cell system in the intestinal mucosa. Nitric oxide is a potent compon
ent of the NANC inhibitory innervation and its synthesizing enzyme, ni
tric oxide synthase (NOS), is shown to be almost absent in the neurona
l system in aganglionic intestine.